Jefferies Financial Group Inc. Sells 25,020 Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)

Jefferies Financial Group Inc. cut its stake in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 50.0% during the 2nd quarter, Holdings Channel reports. The fund owned 25,000 shares of the biotechnology company’s stock after selling 25,020 shares during the period. Jefferies Financial Group Inc.’s holdings in Cerevel Therapeutics were worth $795,000 […]

Related Keywords

United States ,N Anthony Coles ,Scott Akamine ,Piper Sandler ,Morgan Stanley ,Cerevel Therapeutics Holdings Inc ,Holdings Channel ,Charles Schwab Investment Management Inc ,Mirae Asset Global Investments Co ,Jefferies Financial Group Inc ,Nasdaq ,York Mellon Corp ,Securities Exchange Commission ,Affinity Asset Advisors ,Jpmorgan Chase Co ,Jefferies Financial Group ,Cerevel Therapeutics Holdings ,Free Report ,Financial Group ,Cerevel Therapeutics ,Schwab Investment Management ,Asset Advisors ,Asset Global Investments ,New York Mellon Corp ,Therapeutics Holdings ,Get Free Report ,Exchange Commission ,Directorn Anthony Coles ,Visit Holdingschannel ,Cerevel Therapeutics Daily ,Nasdaq Cere ,Racere ,Medical ,15677310 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,